-
公开(公告)号:US20190008963A1
公开(公告)日:2019-01-10
申请号:US16081526
申请日:2017-03-01
发明人: Xue HAN , Richie E. KOHMAN , Susie S. CHA
IPC分类号: A61K41/00 , C07H21/00 , C07C247/10 , A61K47/54 , A61N5/06
摘要: The invention provides oligonucleotide conjugates including a photolabile crosslinker attached to a cargo moiety, e.g., a therapeutic or diagnostic agent. The invention further provides reagents useful in the preparation of such conjugates and methods of their use.
-
公开(公告)号:US20230114205A1
公开(公告)日:2023-04-13
申请号:US17962149
申请日:2022-10-07
摘要: The present disclosure generally relates to compositions and method for delivery, e.g., sustained delivery of active agents, and their use for the treatment of diseases or disorders.
-
公开(公告)号:US11584792B2
公开(公告)日:2023-02-21
申请号:US17501050
申请日:2021-10-14
IPC分类号: C07K16/24 , C07K16/30 , A61K39/395 , A61K45/06 , A61P31/14
摘要: Described herein are methods of treating COVID19 from a coronavirus infection, methods of treating a subject having a coronavirus infection, methods of improving a survival rate of a subject having a coronavirus infection, methods of determining prognosis of a subject having a coronavirus infection, methods of preventing or treating organ-dysfunction or multi-organ dysfunction or failure associated with a coronavirus infection, methods of combinational therapy for a subject having a coronavirus infection, methods of reducing microthrombi formation or low flow organ-ischemia associated with a coronavirus infection by administering a DEspR inhibitor.
-
公开(公告)号:US11572565B2
公开(公告)日:2023-02-07
申请号:US17381780
申请日:2021-07-21
发明人: Wilson Wai Chun Wong , Yage Ding
摘要: The technology described herein is directed to inducible and repressible polypeptides and polypeptide systems. In particular, described herein are split sequence-specific nucleases and split recombinases that are linked to drug-inducible or drug-repressible dimerization domains. In some embodiments, the polypeptides comprise sequestering domains and/or have their expression controlled by an inducible promoter. In multiple aspects described herein are polynucleotides, vectors, cells, and pharmaceutical compositions comprising said polypeptides or polypeptide systems. Also described herein are methods of using said polypeptide systems to modulate the expression of a target polypeptide or to treat a subject in need of a cell therapy.
-
公开(公告)号:US20230017023A1
公开(公告)日:2023-01-19
申请号:US17952732
申请日:2022-09-26
发明人: Hayk Gevorgyan , Milos Popovic
摘要: A ring resonator optical modulator comprises: an optical region in which optical radiation can propagate in a circular path having an inner radius and an outer radius coincident with an outer perimeter of the ring resonator optical modulator; a MOS capacitor structure having an upper gate device layer and a lower body device layer, and an insulating material being disposed between the upper gate device layer and the lower body device layer; and a cladding region. The optical radiation is confined within the optical region. The insulating material has a first region disposed in the optical region having a first thickness and a second region having a second thickness greater than the first thickness, the second region being disposed radially inwardly from the inner radius of the optical region, such that the optical radiation is radially confined toward the outer side of the inner radius of the optical region.
-
公开(公告)号:US11530246B2
公开(公告)日:2022-12-20
申请号:US16875591
申请日:2020-05-15
IPC分类号: C07K14/47
摘要: The technology described herein is directed to regulated synthetic gene expression systems. In one aspect described herein are synthetic transcription factors (synTFs) comprising a DNA binding domain, a transcriptional effector domain, and a regulator protein. In other aspects described herein are gene expression systems comprising said synTFs and methods of treating diseases and disorders using said synTFs.
-
公开(公告)号:US20220387432A1
公开(公告)日:2022-12-08
申请号:US17761703
申请日:2020-09-18
发明人: John Jahangir Alam , David A. Harris , Cheng Fang
IPC分类号: A61K31/519 , A61P25/28
摘要: The present invention provides methods and compositions for treatment of prion disease.
-
公开(公告)号:US20220361782A1
公开(公告)日:2022-11-17
申请号:US17734042
申请日:2022-04-30
发明人: James Galagan , Uros Kuzmanovic
IPC分类号: A61B5/145 , A61B5/1477 , A61B5/1486
摘要: Disclosed is a hormone electrochemical biosensor, e.g. an amperometric biosensor, for the detection of a hormone and measurement of the concentration of a hormone. The disclosed hormone biosensor comprises a hormone-catalyzing enzyme, such as KSDH1. Also described herein are systems comprising an amperometric biosensor, e.g., chronoamperometric biosensor and methods of using the chronoamperometric biosensor.
-
公开(公告)号:US20220356225A1
公开(公告)日:2022-11-10
申请号:US17763122
申请日:2020-09-23
发明人: Kole T. ROYBAL , Iowis ZHU , Raymond LIU , Ahmad S. KHALIL , Divya ISRANI
IPC分类号: C07K14/705 , C07K16/28 , C07K14/725 , A61K35/17 , C12N5/0783
摘要: The present disclosure generally relates to, inter alia, a new class of chimeric Notch receptors containing a synthetic zinc finger transcriptional effector (synZTE) module, engineered to modulate gene expression and cellular activities in a ligand-dependent manner. The new Notch receptors surprisingly retain the ability to transduce signals in response to ligand binding despite that the Notch extracellular subunit, which includes the negative regulatory region previously believed to be essential for the functioning of Notch receptors, is partly or completely deleted. In addition, the synZTE is designed to bind orthogonal DNA target sequences in target organisms which in turn facilitates precise regulation of therapeutic gene expression with minimal off-target activity. Also provided are compositions and methods useful for producing such receptors, nucleic acids encoding same, host cells genetically modified with the nucleic acids, as well as methods for modulating an activity of a cell and/or for treatment of various health conditions.
-
公开(公告)号:US11473104B2
公开(公告)日:2022-10-18
申请号:US15780668
申请日:2015-12-04
申请人: Massachusetts Institute of Technology , Trustees of Boston University , President and Fellows of Harvard College
IPC分类号: C12N15/86 , A61K35/76 , C07K14/245 , C07K14/35 , C12N15/63 , C12N15/70 , C12N15/74 , C07K14/46 , C07K14/435 , C07K14/61
摘要: Provided herein, in some embodiments, are engineered phagemids that comprise at least one synthetic genetic circuit, wherein the at least one synthetic genetic circuit comprises gene sequences encoding at least one non-lytic antimicrobial peptides (AMPs) and/or antibacterial toxin proteins, a stable origin of replication, and a bacteriophage-packaging signal, wherein the engineered phagemid does not comprise some or all gene sequences encoding bacteriophage proteins required for assembly of a bacteriophage particle.
-
-
-
-
-
-
-
-
-